Private Equity
Seventure Partners has sold Cambrooke Therapeutics to Ajinomoto. No financial terms were disclosed. Based in Ayer, Massachusetts, Cambrooke is a provider of medical nutrition products for patients with serious chronic unmet medical needs.
4 min read · 10 November 2017
1 min read · 10 November 2017
1 min read · 10 November 2017
San Francisco-based Welkin Health, a digital health company, has secured $8 million in Series A funding. Thrive Capital led the round.
1 min read · 09 November 2017
San Francisco-based 1984 Ventures, led by entrepreneur and investor Ramy Adeeb, is seeking to raise $75 million for its first venture fund, according to a regulatory filing. Adeeb is the founder and CEO of Snip.it, which was acquired by Yahoo. He is also a onetime principal at Khosla Ventures, where he worked on such investments as Square and Ness Technologies, according to his bio.
1 min read · 09 November 2017
LunaCap Ventures is seeking to raise $30 million for its second fund, according to an SEC filing. The New York-based firm provides venture debt funding to early-stage companies led by military veterans, women and minorities. Paul Capon, a founder and managing partner of LunaCap Ventures, is an Air Force veteran who completed two tours in Afghanistan.
1 min read · 09 November 2017
Swedish contraceptive app Natural Cycles has secured $30 million in Series B funding. EQT Ventures led the round with participation from return backers Sunstone, E-ventures and Bonnier Growth Media.
5 min read · 09 November 2017
1 min read · 09 November 2017
Cambridge, Massachusetts-based Exonics Therapeutics Inc, a biotech company focused on developing gene editing technologies to Duchenne muscular dystrophy and other neuromuscular diseases, has raised $40 million in Series A financing. The backer was The Column Group. In addition to the funding, TCG’s Dr. David Goeddel, a managing partner, and Dr. JJ Kang, a principal, will join Exonics' board of directors.
1 min read · 09 November 2017
4 min read · 09 November 2017
